Case Study: 63-Year-Old Man With Multiple Myeloma

News
Video

A team of multiple myeloma experts review a patient profile, offering preliminary insights and underscoring the importance of advanced practice providers in optimizing patient care.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with a blue border around the image
Image of a woman with dark hair wearing a floral shirt in front of a blurred background
Screenshot of Kiah Purcell, MSN, AGPCNP-BC, in a video call with the frame surrounded by an Oncology Nursing News branded border
Related Content
Image of red blood cells

Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

Ashling Wahner
April 22nd 2025
Article
The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Image of blood cells with myeloma present

Study Findings Support D-VRd for Transplant-Ineligible or -Deferred MM

Kristi Rosa
April 18th 2025
Article

Data from the CEPHEUS trial support the use of D-VRd in patients with transplant-ineligible or -deferred multiple myeloma who can tolerate bortezomib.

Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape

Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape

Lindsay Fischer
April 13th 2023
Podcast

Beth Faiman, PhD, CNP, discusses reclassifying patients with multiple myeloma, the accelerated approval of teclistamab, and the removal of belantamab mafodotin from the US market.

Rendering of red blood cells with multiple myeloma

Elotuzumab/PVd Combo Elicits Response in Relapsed/Refractory MM

Roman Fabbricatore
March 30th 2025
Article

Elotuzumab plus pomalidomide, bortezomib, and dexamethasone showed tolerability in patients with relapsed or refractory multiple myeloma.

Rendering of plasma cells

Daratumumab-Based Regimen Sustains Efficacy in Transplant-Ineligible NDMM

Russ Conroy
March 20th 2025
Article

Updated MAIA trial results reinforce the frontline benefit of daratumumab plus lenalidomide/dexamethasone in transplant-ineligible NDMM.